Lixte Biotechnology Holdings Inc

#137 in public LIXT.US public

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Bitcoin Holdings

Total Bitcoin â‚¿ 10.5 BTC
% of 21M Supply 0.0%
Current Value $804,783
Cost Basis $1,196,832
ROI -32.76%
% of Company 1.1%
mNAV 87.17x
BTC/Share â‚¿ 0.00000096 BTC
Market Cap $72,811,712
Enterprise Value $73,407,130
Latest Purchase Sep 10, 2025
Avg. cost / BTC $113,984

Lixte Biotechnology Holdings Inc Stock Priced in BTC

0.000078 BTC

Lixte Biotechnology Holdings Inc Bitcoin Holdings Over Time

â‚¿ 10.5 BTC

Bitcoin Acquisitions History

Type BTC Change Holdings Transaction Value Date
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —

Get instant access to full data

Register for free

Financial Highlights

Revenue (TTM) $0
Profit Margin 0%
Operating Margin 0%
ROE -101.95%
ROA -46.0%
EPS $-1.15
Book Value $0.902
Current Volume 140,900
Avg Volume (30d) 67,440
Volume vs Avg 2.09x

Lixte Biotechnology Holdings Inc Stock Price vs Bitcoin

$5.88 / $76,646

Company Overview

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Boca Raton, Florida.

Sector Healthcare
Industry Biotechnology
Sub-Industry Biotechnology
Employees 3
Exchange NASDAQ
Fiscal Year End December
IPO Date September 2007

Stock Returns

Share Price $5.88
1W Return +13.95%
1M Return +47.74%
3M Return +102.76%
1Y Return +338.81%
1Y vs BTC +372.7%
52W High $6.26
% Down from 52W High -6.1%

Key Executives

Mr. Geordan G. Pursglove CEO, President & Chairman
Age: 38
Mr. Peter M. Stazzone Chief Financial Officer
Age: 74
Mr. Bastiaan van der Baan M.Sc. Chief Scientific Officer
Age: 54

Company Details

Address 433 Plaza Real, Boca Raton, FL, United States, 33432
Phone 631 830 7092
ISIN US5393192027
CIK 0001335105
Currency USD
Most Recent Quarter 2026-03-31

Growth Metrics

Earnings Growth (YoY) 0%
Revenue Growth (YoY) 0%

Balance Sheet (Q1 2026)

Total Assets $10,865,298
Total Liabilities $1,686,706
Total Equity $7,945,032
Cash & Equivalents $0
Total Debt $595,418
Current Assets $3,407,750
Current Liabilities $1,224,934
Long-term Debt $0

Additional Financials

Gross Profit $0
Revenue per Share $0
Diluted EPS (TTM) $-1.15
PEG Ratio 0
Outstanding Shares 10,889,000

EPS Estimates

Current Quarter $0
Current Year $0
Next Quarter $0
Next Year $0

Recent Insider Activity

Name Title Type Shares Price Value Date SEC
Der Baan Bastiaan Jeroen Van INSIDER Buy 10,000 $2.80 $28,000 Oct 03, 2023

Get instant access to full data

Register for free

Major Holders

Scotia Capital Inc
2.2268%
242,476 shares
Federation des caisses Desjardins du Quebec
0.8038%
87,526 shares
Renaissance Technologies Corp
0.8005%
87,166 shares
Vanguard Group Inc
0.6451%
70,245 shares
DRW Securities, LLC
0.4659%
50,732 shares
Geode Capital Management, LLC
0.449%
48,892 shares
Ethos Financial Group LLC
0.2135%
23,248 shares
State Street Corp
0.1497%
16,301 shares
Two Sigma Investments LLC
0.1306%
14,221 shares
XTX Topco Ltd
0.1252%
13,633 shares
Vanguard Institutional Extnd Mkt Idx Tr
0.4259%
46,376 shares
Fidelity Extended Market Index
0.2453%
26,711 shares
Spartan Extended Market Index Pool F
0.0824%
8,973 shares
NT Ext Equity Mkt Idx Fd - NL
0.0773%
8,417 shares
Fidelity Total Market Index
0.0733%
7,982 shares
Fidelity Series Total Market Index
0.0622%
6,773 shares
NT Ext Equity Mkt Idx Fd - DC - NL - T2
0.0606%
6,599 shares
Spartan Total Market Index Pool G
0.0367%
3,996 shares
Fidelity Nasdaq Composite Index
0.0067%
730 shares
Northern Trust Extended Eq Market Idx
0.0019%
207 shares

Frequently Asked Questions

Common questions about Lixte Biotechnology Holdings Inc's Bitcoin holdings

How much Bitcoin does Lixte Biotechnology Holdings Inc hold?

Lixte Biotechnology Holdings Inc currently holds 10.5 BTC, which represents 0.0% of the total Bitcoin supply (21 million). This makes them the 137th largest public Bitcoin holder.

What is the current value of Lixte Biotechnology Holdings Inc's Bitcoin holdings?

As of today, Lixte Biotechnology Holdings Inc's Bitcoin holdings are worth approximately $804,783. This represents 1.1% of the company's total market value.

What is Lixte Biotechnology Holdings Inc's average cost basis for Bitcoin?

Lixte Biotechnology Holdings Inc's average cost basis for their Bitcoin purchases is $1,196,832 per Bitcoin. Their current return on investment (ROI) is -32.76%.

When did Lixte Biotechnology Holdings Inc last buy Bitcoin?

Lixte Biotechnology Holdings Inc's most recent Bitcoin purchase was Sep 10, 2025. View purchase details

What type of company is Lixte Biotechnology Holdings Inc?

Lixte Biotechnology Holdings Inc is a public company in the Healthcare sector and Biotechnology industry with approximately 3 employees .

What is Lixte Biotechnology Holdings Inc's market capitalization?

Lixte Biotechnology Holdings Inc has a market capitalization of approximately $72,811,712 and annual revenue of $0 .

What is Lixte Biotechnology Holdings Inc's mNAV?

Lixte Biotechnology Holdings Inc's mNAV (Market-to-Net Asset Value) is 87.17x, comparing the company's market value to its Bitcoin holdings value. An mNAV of 1.0 means market value equals Bitcoin stash, while >1.0 indicates a premium for the company's Bitcoin strategy.

What is Lixte Biotechnology Holdings Inc's market cap and enterprise value?

Lixte Biotechnology Holdings Inc has a market capitalization of $72,811,712 and an enterprise value of $73,407,130. Enterprise value represents the total company value including debt and cash, providing a more complete valuation picture than market cap alone.

Chat

You are commenting as a guest. .

alon

Hey @trader, which data isn't updating? Are you talking about the website speed?

Comment from Bitcoin Dashboard

trader

Please why are the data's on newhedge taking so long to updates? I mean hours

Comment from Bitcoin Dashboard

G
Guest
radicalsound277

correct horse battery staple

Comment from Bitcoin Dashboard

G
Guest
sharputxo635

Plain brown wrapper grand forks

Comment from Bitcoin vs Gold Correlation

23 May 2026

G
Guest
radicalhardmoney456

hi

Comment from Bitcoin Dashboard

alon

:)

Comment from Bitcoin Dashboard

G
Guest
silenthodl877

Exchange reserve data! thank you

Comment from Bitcoin Exchange Reserves

G
Guest
peerlessimmutableledger591

Ship captains

Comment from Bitcoin Dashboard

maisonmargiela

Saylor and the ETFs

Comment from Bitcoin Dashboard

G
Guest
autonomousbitcoin141

who is buying?

Comment from Bitcoin Activity Rate

20 May 2026

yousifsamad07

ok

Comment from Bitcoin Total Node Distribution Map

bittynakamoto

I haven't seen a single Saylor tweet about anything defi or ethereum related

19 May 2026

G
Guest
braveselfcustody296

Michael Saylor has been reposting links to DeFi scams built on Ethereum, presumably because they are providing demand for his perpetual preferred stock STRC. As Saylor himself notes, 80% of STRC is owned by retail investors, which makes promoting these DeFi ponzis even more irre

Comment from Bitcoin Dashboard

G
Guest
braveselfcustody296

Saylor is now promoting Ship coins wowwww

Comment from Bitcoin Dashboard

drenchravine

who thinks the Hormuz Bitcoin toll will affect price?

G
Guest
anarchicseed970

apa itu devalusi rupiah

Comment from Bitcoin MVRV Ratio

G
Guest
strongpeer126

gg

Comment from Bitcoin Dashboard

18 May 2026

G
Guest
resistantuncensorable206

When a lot of people buy, the price goes up. If more people start selling than buying, the price goes down

Comment from Bitcoin Dashboard

G
Guest
strongorangepill639

How does this work

Comment from Bitcoin Reachable Node Distribution Live Map

17 May 2026

G
Guest
wildproofwork486

Good write-up. I definitely love this website. Continue the good work!